Insulin CP Pharma Hypurin Porcine Neutral may be available in the countries listed below.
Insulin Injection, Soluble porcine (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulin CP Pharma Hypurin Porcine Neutral in the following countries:
International Drug Name Search
Antivom may be available in the countries listed below.
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Antivom in the following countries:
Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Antivom in the following countries:
International Drug Name Search
Treating certain types of seizures associated with epilepsy when used along with other medicines. It may also be used for treating nerve pain associated with herpes zoster (shingles) infection (postherpetic neuralgia). It may also be used for other conditions as determined by your doctor.
Gabarone is an anticonvulsant. Exactly how it works to prevent seizures and treat nerve pain is not known.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Gabarone. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Gabarone. Tell your health care provider if you are taking any medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Gabarone may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Gabarone as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Gabarone.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Clumsiness; constipation; diarrhea; dizziness; drowsiness; dry mouth; nausea; stomach upset; tiredness; vomiting; weight gain.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); abnormal thoughts; back and forth eye movements; behavioral problems; change in school performance; chest pain; confusion; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; hyperactivity; loss of coordination; memory loss; new or worsening mental or mood changes (eg, depression, agitation, anxiety, panic attacks, aggressiveness, impulsiveness, irritability, hostility, exaggerated feeling of well-being, restlessness, inability to sit still); new or worsening seizures; numbness of an arm or leg; one-sided weakness; severe or persistent headache or dizziness; shortness of breath; speech changes or trouble speaking; suicidal thoughts or actions; swelling of the hands, legs, or feet; tremor; trouble concentrating; twitching; vision changes (eg, double or blurred vision).
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Gabarone side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include diarrhea; double vision; drowsiness; sluggishness; slurred speech.
Store Gabarone between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Gabarone out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Gabarone. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
1.1. Hip joint osteoarthritis
1.2. Hip joint capsule inflammation
1.3. Hip joint osteoarthritis (use with GUNA®-POLYARTHRITIS)
1.4. Hip joint rheumatoid arthritis (use with GUNA®-POLYARTHRITIS)
1.5. Hip pain of muscle origin (use with GUNA®-MUSCLE)
1.6. Hip pain of nerve origin/neuralgia, radicular pain (use with GUNA®-NEURAL)
1.7. Hip joint pain due to prolonged bed rest.
2.1. Standard protocol for IM administration: 1 vial 1-3 times a week according to severity and clinical response.
2.2. Standard protocol according to mesotherapy technique using 1 vial per treatment: 2 treatments for the first 2 weeks, 1 treatment a week till pain relief (average 8-10 sessions). For chronic pathologies: continue 1 treatment a week for 1 month till pain relief, then 1 treatment a month.
Select application site according to trigger points, tender points, referred pain zones, acupuncture points, key nerve points, or “local pain points”. Using a 13 mm, 30G or a 4 mm, 27G needle, make the classic intradermal injection according to mesotherapy technique. Discard unused solution.
2.3. Opening of Vials: Use sterile needles and sterile syringe. Do not reuse. Do not use if foreign particles are present. Draw 1 cc of air into syringe, insert needle into vial inject air and withdraw the solution
3.1. 2 ml glass vials
Each ingredient is attenuated according to the procedures stated in the Homeopathic Pharmacopeia of the United States.
Active ingredients: Arnica montana 8X, Anti interleukin 1 alpha 4C, Anti interleukin 1 beta 4C, Beta-Endorphin 4C, Calcarea fluorica 6X, Cartilago 4X, Colocynthis 8X, Rhus toxicodendron 10X, Argentum metallicum 10X, Collagen 6X.
Inactive ingredient: Sterile isotonic sodium chloride solution.
4.1. There is no history of hypersensitivity to GUNA®-HIP. However patients with a known hypersensitivity to any ingredient should be tested before use. Make a spot injection (0.1ml) into the forearm and observe for any reactions for 1 hour.
5.1. Hip pain requires differential diagnosis for primary or metastatic cancer pain, radicular pain, referred nerve pain from lumbar origin, inguinal hernia.
5.2. Skin cleansing/disinfection is required before application. Saprophytic bacteria may produce injection site abscesses with improper skin preparation.
6.1. The most common mild adverse reaction is slight reddening at the injection site due to the mechanical effect of the needle or a superficial skin reaction of mild erythema.
7.1. None Known.
8.1 Pregnancy: Pregnancy category C. Animal reproduction studies have not been conducted with GUNA®-HIP. GUNA®-HIP should not be given to a pregnant woman.
8.2 Nursing mothers: It is not known whether any of the ingredients in GUNA®-HIP are secreted in human milk. However, since many drugs are secreted in human milk, caution should be exercised when GUNA®-HIP is administered to a nursing woman.
8.3 Pediatric use: No restrictions.
8.4 Geriatric use: No restrictions
9.1. No Known.
10.1. No Known.
11.1. GUNA®-HIP is a sterile solution made with isotonic sodium chloride solution.
It is a homeopathic complex medicine, whose active ingredients have been selected in order to promote 2 main activities:
• Detoxification of the connective tissue matrix
• Pain modulation through stimulation of the physiological mechanisms of pain control.
The attenuation of the biological substrates acts to target the area of activity of the product.
12.1. Mechanism of Action
Due to the homeopathic nature of the active ingredients, receptors may be activated by feedback regulation. Beta-endorphins at the 4C dose activate the membrane receptor for endogenous endorphins that play a key role in pain relief. Anti IL-1 induces a down regulation of IL-1 inflammatory activity.
12.2. Pharmacodynamics
The physiological effects of GUNA®-HIP are due to the action of the ingredients as described in the Homeopathic Materia Medica.
In Homeopathy there is no direct relationship between dose and effect, but rather there is a relationship between attenuation and balancing effect on biochemical pathways.
In GUNA®-HIP the attenuation of each ingredient has been selected according to the Arndt-Schulz Principle (inverted effect law). Attenuation of the physiological ingredients promotes membrane receptor feedback in order to normalize altered biological pathways. In Addition the attenuation technique activates the low dilutions and stabilizes clinical activity of the compound.
12.3. Pharmacokinetics
Homeopathic attenuation provides complete bioavailability of the active ingredients.
13.1. GUNA®-HIP has no level of toxicity due to the attenuation of the ingredients.
14.1. GUNA®-HIP formulation is based on classical Homeopathy and each ingredient has been selected according to its description in the Homeopathic Materia Medica. The product is intended for application to target points such as acupuncture points, Weihe points, and key neurologic points.
Clinical indications for the key ingredients:
Anti interleukin-1 alpha 4C / Anti interleukin-1 beta 4C:
• Biological classification: Interleukin 1 receptor antagonist (IL-1ra) belongs to the IL-1 family. Endogenous IL-1ra is produced in human autoimmune and chronic inflammatory diseases.
• Etiopathogenesis: It binds to IL-1 receptors in competition with IL-1, but does not elicit intracellular response from this binding. Its key role is counteracting the proinflammatory effects of IL-1.
• Space-time localization: It is next to Arnica. Reference group: Arnica-Mercurius.
• Clinical: Immunological based diseases, autoimmune and chronic inflammatory diseases, acute and chronic pain, osteoarthritis, chronic arthritis, inflammatory psoriasis, wet eczema, localised inflammatory swelling. Appropriate for local application.
• Modalities: Worsens with cold and movement. Improves with rest and warm.
• Association with other cell mediators: TNF 15C / IL8 4C /
NT4 4C / GCSF 4C.
Beta-Endorphin 4C:
• Biological classification: Neuropeptide and neurotransmitter. It is produced by the anterior lobe of the hypophysis and by the hypothalamus.
• Etiopathogenesis: It acts on the mechanism that enhances pain. It suppresses the memory of painful events and negative experiences.
• Space-time localization: It is next to Arnica.
Reference group: Mercurius.
• Clinical: Pain management by enhancing the immune response. It acts on modulating pain, cardiac, gastric and vascular function as well as panic syndrome and satiation. Organic and functional pain. Remedy for somatization disorders. It enhances acupuncture sessions. Antidepressive activity. It may improve individual positive attitudes.
• Modalities: Worsens due to fatigue and intensive exercise.
• Association with other cell mediators: Sepia / Arnica / Aconitum / Bromum / Aurum / Iodium / IL6 4C/ Melatonin 15C, 30C, 12LM, 18LM, 30LM / NT4 4C / BDNF 4C.
15.1. I. Bianchi: Citochine e Interferoni. Farmacologia e Clinica. Nuova IPSA Editore.
15.2. L. Milani: Weihe e altri Punti tra Agopuntura e Omeopatia. Guna Editore.
15.3. J. Malzac: Materia Medica Immunologia. IPSA Editore.
15.4. H.H. Reckeweg. Homeopathic Materia Medica. Aurelia Verlag.
17.1. Patients should be informed about Homeopathy and Acupuncture and the main differences with conventional clinical approaches.
| Guna-Hip arnica montana - calcium fluoride - canakinumab - metenkefalin - silver - sus scrofa cartilage - sus scrofa collagen - toxicodendron pubescens leaf - citrullus colocynthis fruit pulp - anti-interleukin-1.alpha. immunoglobulin g rabbit - injection, solution | ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved homeopathic | 09/29/2006 | ||
| Labeler - Guna spa (430538264) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Guna spa | 430538264 | manufacture | |
Treating severe low blood sugar in patients with diabetes who are unable to take sugar by mouth. GlucaGen also may be used for other conditions as determined by your doctor.
GlucaGen is a hormone. It works by stimulating the liver to release glucose into the blood.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with GlucaGen. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with GlucaGen. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if GlucaGen may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use GlucaGen as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use GlucaGen.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Nausea; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing or swallowing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue); fainting; fast or slow heartbeat; severe headache or dizziness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: GlucaGen side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include diarrhea; fast heartbeat; nausea; severe headache or dizziness; vomiting.
Before mixing, store GlucaGen for up to 24 months between 68 and 77 degrees F (20 and 25 degrees C). Do not freeze. Store in the original packaging away from heat, moisture, and light. Do not store in the bathroom. After mixing, use immediately. Do not use GlucaGen after the expiration date printed on the package. Keep GlucaGen out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about GlucaGen. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Using Gallium with other medicines that may harm the kidneys (eg, aminoglycosides [eg, gentamicin], amphotericin B) may increase your risk of developing severe kidney problems. Make sure you notify your health care provider of any other medicines that you are taking before using this one.
Treating high calcium levels in the blood caused by cancer in patients who do not respond to proper fluid intake or fluid injected into the vein.
Gallium is a calcium resorption inhibitor. It works by inhibiting the usual release of calcium from the bone into the blood.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Gallium. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Gallium. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Gallium may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Gallium as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Gallium.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; mouth sores; weakness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal dreams; changes in vision; chills; confusion; decreased urination or dark urine; difficulty breathing; dry mouth; fast heartbeat; hallucinations; increased urination at night; muscle cramps; nausea; ringing in the ear; swelling of ankles or feet; unpleasant taste; vomiting.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dark urine; difficulty urinating; nausea; vomiting.
Store Gallium at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Throw away the unused portion. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Gallium out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Gallium. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Lifo-Scrub may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Lifo-Scrub in the following countries:
International Drug Name Search
